Multi Criteria Decision Analysis Methods In Health Care: Current Status, Good Practice And Future Recommendations

Abstract

lenges and opportunities. Results: Only 22%-27% of payers and providers believe that personalized medicine is a "very important" strategic goal versus ~50% of large biopharma manufacturers. Although 47%-52% of all stakeholders have integrated staff with area expertise, fewer than 20% have developed a centralized focus on personalized medicine and only 8%-20% believe they have tools to evaluate its success. Decision maker perspectives ranged broadly on its key benefits but included improved and more predictable outcomes and cost efficiencies. Approximately 30% of all stakeholders believe that personalized medicines will continue to receive premium pricing to justify ROI for this business approach. ConClusions: Although most stakeholders see value in personalized medicines, they struggle with practical implementation and need actionable strategies to characterize the value and impact of these technologies. The survey suggests that limited emphasis on infrastructure development and methods, heterogeneous value assessment, and misalignment of incentives remain key challenges to enabling care and economic efficiencies promised by this evolving treatment paradigm.

Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward

“…Recent years have witnessed an increased interest in the use of multicriteria decision analysis (MCDA) to support health technology assessment (HTA) agencies in setting healthcare priorities. [1][2][3][4][5][6] MCDA offers decision makers a structured way to include the different values that society holds. The term values here refers to both the therapeutic benefits of a technology for patients and their broader social impact.…”

Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges

“…PBMA and MCDA are both systematic processes to aid resource prioritization decisions which involve assessing the available options against a set of criteria (see [22] , [23] for detailed explanations). SROI studies demonstrate the return on an investment considering a wider remit than standard ROI as the benefits to society are also included.…”

Patient-centric HTA: different strokes for different folks

“…Baltussen et al [27] describe a set of criteria composed of the societal wishes to maximize: general population health; the distribution of healthcare; specific societal preferences; budgetary and practical constraints; and political criteria; however, they also note that individual importance within multiple criteria is not always equal and, therefore, requires prioritization. However, no guidelines exist on how to select the best MCDA technique for certain decision problems in healthcare [30].…”